trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['ovarian', 'solid tumor', 'pantumor', 't-dxd']
#asco23 efficacy and safety of t-dxd in pts with her2-expressing solid tumors: destiny-pantumor02 267 pts (t-dxd 5,4 mg/kg) orr
ihc 3+ 61.3%
ihc 2+ 27.2%
&gt;40% in #ovariancancer, #cervicalcancer and #endometrialcancer any grade ild 7.5% 
OncoClic est une application spécialisée en Oncologie, nous développons des outils. #clinicaltrial #yoc #cancer #oncologie #oncology #ehealth #esante #oncoclic